Yi Qin

8.9k total citations · 2 hit papers
215 papers, 6.7k citations indexed

About

Yi Qin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi Qin has authored 215 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Molecular Biology, 78 papers in Oncology and 42 papers in Cancer Research. Recurrent topics in Yi Qin's work include Pancreatic and Hepatic Oncology Research (45 papers), Epigenetics and DNA Methylation (26 papers) and Neuroendocrine Tumor Research Advances (24 papers). Yi Qin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (45 papers), Epigenetics and DNA Methylation (26 papers) and Neuroendocrine Tumor Research Advances (24 papers). Yi Qin collaborates with scholars based in China, United States and Japan. Yi Qin's co-authors include Xianjun Yu, Shunrong Ji, Jin Xu, Wenyan Xu, Xiaowu Xu, Qiangsheng Hu, Si Shi, Quanxing Ni, Wensheng Liu and Qiqing Sun and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Yi Qin

207 papers receiving 6.6k citations

Hit Papers

Lactate‐induced protein lactylation: A bridge between epi... 2023 2026 2024 2025 2023 2024 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Qin China 44 3.6k 1.9k 1.8k 799 771 215 6.7k
Yanru Wang China 43 4.0k 1.1× 1.2k 0.6× 1.4k 0.8× 704 0.9× 864 1.1× 226 6.7k
Hongbing Zhang China 49 5.6k 1.6× 1.6k 0.9× 1.5k 0.8× 817 1.0× 1.1k 1.4× 197 9.2k
Hiroto Izumi Japan 54 6.6k 1.8× 1.7k 0.9× 2.1k 1.2× 1.0k 1.3× 1.2k 1.6× 211 9.9k
Zhiping Li China 44 3.9k 1.1× 1.2k 0.6× 1.8k 1.0× 529 0.7× 388 0.5× 174 7.1k
Peng Jiang China 42 4.1k 1.1× 1.9k 1.0× 1.0k 0.6× 427 0.5× 567 0.7× 149 6.4k
Liu L China 53 6.3k 1.7× 4.0k 2.1× 1.4k 0.8× 536 0.7× 797 1.0× 425 10.4k
Jun Kanno Japan 45 3.6k 1.0× 947 0.5× 1.0k 0.6× 553 0.7× 843 1.1× 194 8.5k
Jianrong Lu United States 44 8.3k 2.3× 2.3k 1.2× 1.6k 0.9× 488 0.6× 675 0.9× 92 10.6k
Wei‐Chien Huang Taiwan 44 3.2k 0.9× 1.2k 0.6× 1.3k 0.7× 481 0.6× 644 0.8× 123 5.8k
Bart Ghesquière Belgium 41 3.9k 1.1× 1.7k 0.9× 719 0.4× 363 0.5× 1.5k 1.9× 106 6.6k

Countries citing papers authored by Yi Qin

Since Specialization
Citations

This map shows the geographic impact of Yi Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Qin more than expected).

Fields of papers citing papers by Yi Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Qin. The network helps show where Yi Qin may publish in the future.

Co-authorship network of co-authors of Yi Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Qin. A scholar is included among the top collaborators of Yi Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Qin. Yi Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Borui, Ting Wang, Haifeng Hu, et al.. (2025). Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. Acta Pharmacologica Sinica. 46(6). 1742–1756. 4 indexed citations
2.
Xie, Changqing, Ting Wang, Yan Wang, et al.. (2025). Liquid–Liquid Phase Separation in Major Hallmarks of Cancer. Cell Proliferation. 59(2). e70122–e70122. 1 indexed citations
3.
Jia, Yewei, Rui Li, Yixuan Li, et al.. (2025). Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis. Bone Research. 13(1). 9–9. 5 indexed citations
4.
Yu, Zhicai, Zhenyu Zhu, Yingzi Zhang, et al.. (2024). Biodegradable and flame-retardant cellulose-based wearable triboelectric nanogenerator for mechanical energy harvesting in firefighting clothing. Carbohydrate Polymers. 334. 122040–122040. 98 indexed citations breakdown →
5.
Fan, Guixiong, Qin Dang, Shunrong Ji, et al.. (2024). Transcription factor EB reprograms branched‐chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1. Cell Proliferation. 57(11). e13694–e13694. 7 indexed citations
6.
Wu, Di, Yue Zhang, Weibo Chen, et al.. (2024). PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis. Experimental Cell Research. 439(1). 114074–114074. 1 indexed citations
7.
Zeng, Ye, Qiang Li, Wuhu Zhang, et al.. (2024). The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Cancer Letters. 588. 216769–216769. 9 indexed citations
8.
Yu, Zhicai, Zhenyu Zhu, Yushu Wang, et al.. (2023). Wearable cotton fabric-based single-electrode-mode triboelectric nanogenerator for self‑powered human motion monitoring. Cellulose. 30(8). 5355–5371. 28 indexed citations
9.
Zhang, Ruoxin, Dakui Luo, Zezhi Shan, et al.. (2023). PROX1 restrains ferroptosis via SCD transcription activation in colorectal cancer. Acta Biochimica et Biophysica Sinica. 55(4). 691–694. 3 indexed citations
10.
Wang, Ting, Yi Qin, Ye Zeng, et al.. (2023). A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. Acta Pharmacologica Sinica. 44(8). 1536–1548. 12 indexed citations
11.
Zhuo, Qifeng, Heli Gao, Yi Qin, et al.. (2023). MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression. Cancer Research. 83(13). 2226–2247. 20 indexed citations
12.
Zeng, Ye, Zheng Li, Guixiong Fan, et al.. (2023). Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Proliferation. 56(10). e13478–e13478. 107 indexed citations breakdown →
13.
Zhang, Yuting, Wen Qin, Wenhui Zhang, Yi Qin, & You Lang Zhou. (2022). Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes. Clinical & Translational Oncology. 25(4). 959–975. 2 indexed citations
14.
Liu, Mengqi, Yi Qin, Qiangsheng Hu, et al.. (2020). SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. Cancer Letters. 499. 265–278. 22 indexed citations
15.
16.
Sun, Qiqing, Yiyin Zhang, Mengqi Liu, et al.. (2019). Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis. Cancer Cell International. 19(1). 309–309. 20 indexed citations
17.
Liang, Chen, Yi Qin, Bo Zhang, et al.. (2017). Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Research. 15(2). 201–212. 46 indexed citations
18.
Li, Qingguo, Yi Qin, Ping Wei, et al.. (2016). Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Molecular Cancer Research. 14(9). 830–840. 50 indexed citations
19.
Ji, Shunrong, Yi Qin, Chen Liang, et al.. (2016). FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer. Clinical Cancer Research. 22(15). 3950–3960. 76 indexed citations
20.
Zhu, Kai, Zhi Dai, Qi Pan, et al.. (2011). Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition. Clinical Cancer Research. 17(23). 7294–7302. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026